Increased expression of TOP2A, thymidylate synthase, TUBB3 and mutations in PIK3CA and PTEN in HCC metastases suggest that they may be less responsive to 5-fluorouracil and taxanes, but more sensitive to anthracyclines and mTOR inhibitors. Here, MTOR is linked to hepatocellular carcinoma.